A Phase 2 Randomized Controlled Trial Repurposing Ambroxol as a Disease Modifying Treatment for Parkinson's disease Dementia.

被引：0
|
作者：
Pasternak, S. H.
Silviera, C.
Coleman, K.
Finger, E.
Wells, J.
Borrie, M.
Morrow, S.
Zou, G.
Bartha, R.
Macdonald, P.
Jenkins, M. E.
Jog, M.
Tirona, R.
Rupar, C. A.
机构：
来源：
MOVEMENT DISORDERS | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
429
引用
收藏
页码：S189 / S190
页数：2
相关论文
共 50 条
  • [21] TREATMENT OF PSYCHOSIS IN PARKINSON'S DISEASE AND PARKINSON'S DISEASE DEMENTIA
    Ballard, Clive
    Mills, R.
    Williams, H.
    Corbett, A.
    Cummings, J.
    NEUROBIOLOGY OF AGING, 2014, 35 : S2 - S2
  • [22] Interpersonal Psychotherapy for the Treatment of Depression in Parkinson's Disease: Results of a Randomized Controlled Trial
    Koszycki, Diana
    Taljaard, Monica
    Bradwejn, Jacques
    Lee, Caroline
    Tasca, Giorgio A.
    Grimes, David A.
    MOVEMENT DISORDERS, 2024,
  • [23] Mild cognitive impairment in idiopathic Parkinson's disease without dementia.
    Hurtado Gonzalez, C. A.
    Ladera, V
    Perea, M., V
    Garcia, R.
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (08): : 3635 - 3640
  • [24] Bee Venom for the Treatment of Parkinson Disease - A Randomized Controlled Clinical Trial
    Hartmann, Andreas
    Mullner, Julia
    Meier, Niklaus
    Hesekamp, Helke
    van Meerbeeck, Priscilla
    Habert, Marie-Odile
    Kas, Aurelie
    Tanguy, Marie-Laure
    Mazmanian, Merry
    Oya, Herve
    Abuaf, Nissen
    Gaouar, Hafida
    Salhi, Sabrina
    Charbonnier-Beaupel, Fanny
    Fievet, Marie-Helene
    Galanaud, Damien
    Arguillere, Sophie
    Roze, Emmanuel
    Degos, Bertrand
    Grabli, David
    Lacomblez, Lucette
    Hubsch, Cecile
    Vidailhet, Marie
    Bonnet, Anne-Marie
    Corvol, Jean-Christophe
    Schupbach, Michael
    PLOS ONE, 2016, 11 (07):
  • [25] Precision Medicine for Parkinson's Disease: Ambroxol for Glucocerebrosidase-Associated Parkinson's Disease, First Trial Completed
    Schneider, Susanne A.
    Alcalay, Roy N.
    MOVEMENT DISORDERS, 2020, 35 (07) : 1134 - 1135
  • [26] Patient Education for Patients with Parkinson's Disease - A Randomized Controlled Trial
    Magdalena, Chlond
    Felicitas, Bergmann
    Heike, Schnoor
    Karla, Eggert
    Astrid, Larisch
    ZEITSCHRIFT FUR PSYCHOSOMATISCHE MEDIZIN UND PSYCHOTHERAPIE, 2013, 59 (01): : 68 - 69
  • [27] Randomized controlled trial of the Alexander Technique for idiopathic Parkinson's disease
    Stallibrass, C
    Sissons, P
    Chalmers, C
    CLINICAL REHABILITATION, 2002, 16 (07) : 695 - 708
  • [28] A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease
    Shoulson, I
    Penney, J
    McDermott, M
    Kieburtz, K
    Schwid, SR
    Kayson, E
    Chase, T
    Fahn, S
    Greenamyre, JT
    Lang, A
    Siderowf, A
    Pearson, N
    Harrison, M
    Rost-Ruffner, E
    Colcher, A
    Lloyd, M
    Matthews, M
    Pahwa, R
    McGuire, D
    Lew, MF
    Schuman, S
    Marek, K
    Broshjeit, S
    Factor, S
    Brown, D
    Feigin, A
    Mazurkiewicz, J
    Ford, B
    Jennings, D
    Dillon, S
    Comella, C
    Blasucci, L
    Janko, K
    Shulman, L
    Wiener, W
    Bateman-Rodriguez, D
    Carrion, A
    Suchowersky, O
    Lafontaine, AL
    Pantella, C
    Siemers, E
    Belden, J
    Davies, R
    Lannon, M
    Grimes, D
    Gray, P
    Martin, W
    Kennedy, L
    Adler, C
    Newman, S
    NEUROLOGY, 2001, 56 (04) : 455 - 462
  • [29] Effects of cognitive training in Parkinson's disease: A randomized controlled trial
    Petrelli, Annette
    Kaesberg, Stephanie
    Barbe, Michael T.
    Timmermann, Lars
    Fink, Gereon R.
    Kessler, Josef
    Kalbe, Elke
    PARKINSONISM & RELATED DISORDERS, 2014, 20 (11) : 1196 - 1202
  • [30] Randomized-placebo controlled trial of donepezil in Parkinson's disease
    Leroi, I.
    Brandt, J.
    Reich, S. G.
    Lyketsos, C. G.
    Grill, S.
    Thompson, R.
    Marsh, L.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 289 - 290
12345